Prothena Corp Public (PRTA) Assets Average (2013 - 2026)
Prothena Corp Public's (PRTA) quarterly Assets Average came in at $338.3 million in Q1 2026, down 35.09% year-on-year from $521.2 million in Q1 2025, and little changed quarter-over-quarter from $339.7 million in Q4 2025.
Prothena Corp Public (PRTA) Assets Average (2013 - 2026) Analysis & Trends
Prothena Corp Public's Assets Average history runs 14 years deep, the most recent figure standing at $338.3 million for Q1 2026.
- On a quarterly basis, Assets Average fell 35.09% year-over-year to $338.3 million in Q1 2026; TTM through Mar 2026 was $338.3 million, a 35.09% decrease from a year earlier, with the FY2025 full-year figure at $437.0 million, down 29.72% from the prior year.
- Assets Average steadied at $338.3 million in Q1 2026 per PRTA's latest filing, from $339.7 million in the prior quarter.
- Across five years, Assets Average topped out at $749.8 million in Q1 2023 and bottomed at $338.3 million in Q1 2026.
- The 5-year median for Assets Average is $595.4 million (2022), against an average of $577.3 million.
- Across the five-year window, Assets Average soared 67.08% in 2022 and tumbled 40.52% in 2025, its largest moves.
- Year by year, Assets Average stood at $656.2 million in 2022, then advanced by 9.97% to $721.7 million in 2023, then declined by 20.85% to $571.2 million in 2024, then tumbled by 40.52% to $339.7 million in 2025, then declined by 0.4% to $338.3 million in 2026.
- Per Business Quant, the three latest PRTA Assets Average figures stand at $338.3 million (Q1 2026), $339.7 million (Q4 2025), and $375.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 338.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 338.35 Mn |
| Dec 31, 2025 | 339.72 Mn |
| Sep 30, 2025 | 375.85 Mn |
| Jun 30, 2025 | 447.20 Mn |
| Mar 31, 2025 | 521.22 Mn |
| Dec 31, 2024 | 571.18 Mn |
| Sep 30, 2024 | 620.41 Mn |
| Jun 30, 2024 | 634.38 Mn |
| Mar 31, 2024 | 659.79 Mn |
| Dec 31, 2023 | 721.65 Mn |
| Sep 30, 2023 | 733.78 Mn |
| Jun 30, 2023 | 731.12 Mn |
| Mar 31, 2023 | 749.81 Mn |
| Dec 31, 2022 | 656.24 Mn |
| Sep 30, 2022 | 552.01 Mn |
| Jun 30, 2022 | 565.50 Mn |
| Mar 31, 2022 | 595.39 Mn |
| Dec 31, 2021 | 621.04 Mn |
| Sep 30, 2021 | 534.54 Mn |
| Jun 30, 2021 | 408.05 Mn |